Biotechnology News

October 18, 2012

PLEASANTON, Calif.--(BUSINESS WIRE)--Veeva Systems announces today that Vault eTMF, the first electronic trial master file (eTMF) solution developed from the ground up as a multitenant cloud-based service, is now generally available. With full...

October 17, 2012

LOS ANGELES--(BUSINESS WIRE)--CytRx Corporation (Nasdaq: CYTR), a biopharmaceutical research and development company specializing in oncology, announced today the pricing of its previously announced underwritten public offering. CytRx is offering...

October 17, 2012

ST. PAUL, Minn.--(BUSINESS WIRE)--Cardiovascular Systems, Inc. (CSI) (NASDAQ: CSII), announced today that new findings regarding arterial calcification will be unveiled at the 2012 TCT conference.

October 17, 2012

KNOXVILLE, Tenn.--(BUSINESS WIRE)--Provectus Pharmaceticals has terminated its proposed convertible preferred stock offering because of current market conditions.

October 17, 2012

LOS ANGELES--(BUSINESS WIRE)--CytRx Corporation (Nasdaq: CYTR), a biopharmaceutical research and development company specializing in oncology, announced today its intention, subject to market and other conditions, to commence a public offering of...

October 17, 2012

PALO ALTO, Calif.--(BUSINESS WIRE)--Anacor Pharmaceuticals (NASDAQ:ANAC) today announced its intention to offer, subject to market and other conditions, shares of its common stock in an underwritten public offering. Anacor also expects to grant...

October 17, 2012

GREENSBORO, N.C.--(BUSINESS WIRE)--Cone Health Lowers Infection Rates With Innovative Infection Prevention Program Including Use of Xenex Room Disinfection Systems

October 17, 2012

BOSTON & GENEVA--(BUSINESS WIRE)--Global patient-driven eData Systems provider PHT Corporation announced that registration is open to clinical research professionals for the 9th PRO & eCOA Congress, March 26-28, 2013, Baltimore.

October 17, 2012

NEW YORK--(BUSINESS WIRE)--FertilityAuthority launches a new egg freezing website, www.eggfreezingcosts.com, where women can find trusted information on egg freezing...

October 17, 2012

INDIANAPOLIS--(BUSINESS WIRE)--Nexxt Spine, a leading manufacturer of spinal implants and surgical instrumentation, is pleased to announce that it has launched its new and improved website.

October 17, 2012

MADISON, Wis.--(BUSINESS WIRE)--Exact Sciences Corp. today announced that it will host its third-quarter webcast and conference call on Oct. 30, 2012.

October 17, 2012

BOTHELL, Wash.--(BUSINESS WIRE)--Seattle Genetics, Inc. (Nasdaq:SGEN) today announced the initiation of a phase II clinical trial evaluating ADCETRIS (brentuximab vedotin) as a front-line therapy for patients age 60 or older with newly diagnosed...

October 17, 2012

ARDEN HILLS, Minn.--(BUSINESS WIRE)--IntriCon Corporation (NASDAQ: IIN), a designer, developer, manufacturer and distributor of miniature and micro-miniature body-worn devices, today announced it will introduce Audion6™, its new six-channel...

October 17, 2012

EXTON, Pa.--(BUSINESS WIRE)--BioTrends Research Group, one of the world’s leading research and advisory firms for specialized biopharmaceutical issues, finds that trial and uptake of Genentech’s Lucentis 0.3mg, the first and only approved...

October 17, 2012

BELMONT, Mass.--(BUSINESS WIRE)--CLD's Basics of Oncology module holds gold for Best Custom Content & Web site Element/eLearning categories. The module is part iKnow fundamentals of oncology series designed for pharmaceutical reps.

October 17, 2012

ANN ARBOR, Mich.--(BUSINESS WIRE)--Truven Health Analytics Solution Slashes Time to Analyze Patient Healthcare Patterns in Big Data Repository

October 17, 2012

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--A recent study of life sciences companies found that 69% of medical device and small drug companies experience long regulatory submission timelines.

October 17, 2012

PRINCETON, N.J.--(BUSINESS WIRE)--Bristol-Myers Squibb Company (NYSE: BMY) today announced that YERVOY® (ipilimumab), a novel immunotherapy and the first medicine approved for unresectable or metastatic melanoma in more than a decade, received...

October 17, 2012

WILMINGTON, Mass.--(BUSINESS WIRE)--Charles River Laboratories selected by AstraZeneca as its preferred strategic partner for outsourced regulated safety assessment and development DMPK

October 17, 2012

PALO ALTO, Calif., & DEERFIELD, Ill.--(BUSINESS WIRE)--Affymax, Inc. (Nasdaq: AFFY) and Takeda Pharmaceuticals U.S.A., Inc. (TPUSA), today announced that multiple abstracts on OMONTYS® (peginesatide) Injection have been accepted for...

October 17, 2012

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Novella Clinical Resourcing launched its Physician Network, to support biopharmaceutical and medical device companies with strategic development and medical consultative services.

October 17, 2012

PORTLAND, Ore.--(BUSINESS WIRE)--CytoDyn completes acquisition of Pro 140, an experimental humanized monoclonal antibody (mAb) targeting the CCR5 receptor for the treatment and prevention of HIV

October 17, 2012

JERUSALEM, Israel--(BUSINESS WIRE)--Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) announced today that it will release its third quarter 2012 financial results on Thursday, November 1, 2012 at 7:00 a.m. EDT. Teva will host a conference call...

October 17, 2012

WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside of the United States and Canada, announced today that VICTRELIS® (boceprevir) 200 mg Capsules, the company’s oral treatment for chronic hepatitis C genotype 1...

October 17, 2012

ST. PAUL, Minn.--(BUSINESS WIRE)--St. Jude Medical, Inc. (NYSE: STJ) today reported sales and net earnings for the third quarter ended September 29, 2012. Third Quarter Sales The Company reported net sales of $1.326 billion in the third quarter...

October 17, 2012

BURLINGTON, Mass.--(BUSINESS WIRE)--Dyax Corp. (NASDAQ: DYAX) will host a webcast and conference call, including an open question and answer session, Wednesday, October 24, 2012. During the call, management will discuss the Company’s financial...

October 17, 2012

SUNNYVALE, Calif.--(BUSINESS WIRE)--Elixir Medical Announces Schedule for TCT 2012: 3 Year Follow-Up Data for DESyne Novolimus Eluting CSS and 1 Year Follow-Up Data for the DESolve Bioresorbable Scaffold System to be presented.

October 17, 2012

LEXINGTON, Mass.--(BUSINESS WIRE)--Predictive Biosciences, an innovative developer of molecular diagnostic tests, announced today that a case study using the CertNDx™  Bladder Cancer Assay was published in BMC Urology by Dr. Daniel M. Silverberg...

October 17, 2012

NEW YORK--(BUSINESS WIRE)--SV Life Sciences and Third Rock Ventures Launch Transformative Medical Device Company Cibiem with $10 Million Series A

October 17, 2012

LIMERICK, Pa.--(BUSINESS WIRE)--Teleflex Announces Third Quarter 2012 Conference Call Information

October 17, 2012

--(BUSINESS WIRE)--Jim Greenwood will discuss the RFS and opposition to the current waiver requests to EPA.

October 17, 2012

NEWTOWN, Pa.--(BUSINESS WIRE)--BioClinica will issue its 3rd quarter 2012 financial results and host a conference call/webcast on November 8, 2012. The conference call will be held at 11:00 a.m. EST.

October 16, 2012

MISGAV, Israel & SAN FRANCISCO--(BUSINESS WIRE)--Medgenics, Inc. (NYSE MKT: MDGN and AIM: MEDU, MEDG) (the “Company”) today announced that it has filed a shelf registration statement on Form S-3 with the Securities and Exchange Commission (“...

October 16, 2012

LIMERICK, Pa.--(BUSINESS WIRE)--Teleflex Launches "Never Settle" Brand Campaign at AVA Conference to Celebrate ARROW Technologies and the Hard-Working Clinicians Who Use Them

October 16, 2012

FOSTER CITY, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) announced today that its third quarter 2012 financial results will be released on Tuesday, October 23, at 4:05 p.m. Eastern Time. At 4:15 p.m. Eastern Time, Gilead’s...

October 16, 2012

LEWISVILLE, Texas--(BUSINESS WIRE)--Orthofix International N.V., (NASDAQ:OFIX) (the Company) announced today that it has promoted Brian McCollum to President of the Spine Global Business Unit. Mr. McCollum will continue to serve as the Company’s...

October 16, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Vertex will announce its third quarter 2012 financial results on Monday, October 29, 2012 after the financial markets close. The company will host a conference call at 5:00 p.m. EDT.

October 16, 2012

PALO ALTO, Calif.--(BUSINESS WIRE)--Hercules Technology Growth Capital, Inc. (NYSE: HTGC), the leading specialty finance company focused on providing senior secured loans to venture capital-backed companies in technology-related markets,...

October 16, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Regulatory News: Cellectis bioresearch, the specialist in genome customization and commercial subsidiary of Cellectis (Paris:ALCLS) (Alternext: ALCLS), announces that it has been awarded a contract to provide...

October 16, 2012

--(BUSINESS WIRE)--Jim Greenwood will discuss the RFS and opposition to the current waiver requests to EPA.

October 16, 2012

MINNEAPOLIS--(BUSINESS WIRE)--New technique for detecting and classifying COPD will improve the diagnosis and treatment of lung disease.

October 16, 2012

NEWARK, Del.--(BUSINESS WIRE)--Fraunhofer and the University of Delaware will host a technology summit, “Energy and Life Sciences — Solutions for Sustainability,” on Oct. 29-30.

October 16, 2012

PARIS--(BUSINESS WIRE)--Regulatory News: AB Science SA (NYSE Euronext - FR0010557264 - AB), a pharmaceutical company specializing in the research, development and commercialization of protein kinase inhibitors (PKIs), confirms the filing to EMA...

October 16, 2012

PRINCETON, N.J.--(BUSINESS WIRE)--BMS to Present New Data Demonstrating Company’s Continuing Commitment to Research and Development in Liver Disease at AASLD

October 16, 2012

CARLSBAD, Calif. & ZURICH & NETANYA, Israel--(BUSINESS WIRE)--EBD Group, the leading partnering firm for the life science industry, today announced the formation of an alliance with d&a Visual Insights™, an Israel-based decision...

October 16, 2012

GAINESVILLE, Fla.--(BUSINESS WIRE)--Exactech, Inc. (Nasdaq: EXAC), a developer and producer of bone and joint restoration products for hip, knee, shoulder, spine and biologic materials, will release its third quarter 2012 financial results on...

October 16, 2012

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Three quarters of pharmaceutical companies use medical science liaisons (MSLs) to support investigator initiated trials (IITs) following the launch of new drugs, according to a new study.